# QuidelOrtho Corporation (QDEL)

> Source: Nexqual · https://nexqual.com/QDEL · data as of 2026-10-29 20:00 UTC · cite as "Nexqual, QuidelOrtho Corporation (QDEL), nexqual.com/QDEL" · informational, not investment advice.

**Price:** USD 13.76 (-1.78% on the day) · last close of Oct 29, 2026; US market closed, not a live price. Prev close 14.01 · day 13.64–14.26 · 52w 9.92–35.58 · market cap $944M · NMS

## Key facts
- Last four reported quarters (through Jun 28, 2026): revenue $2.67B, net income -$1.05B (-39.2% margin), free cash flow -$211M (SEC filings).
- Analysts: Hold (mean 3.33 on a 1–5 scale) (3 analysts), mean target USD 14.67 (range 12–20).
- Total return with dividends: 1Y -47.7% vs S&P 500 +14.8%; 5Y -89.6% vs S&P 500 +79.1%.
- Next earnings: 2026-11-03, EPS estimate USD 0.18, revenue estimate $628M. All companies reporting that day: https://nexqual.com/earnings/2026-11-03
- Dividend: QDEL paid no cash dividend in the last five years.
- Short interest: 25.83% of float (as of 2026-10-15), 6.3 days to cover.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.70B | $3.27B | $3.00B | $2.78B | $2.73B | $2.67B |
| Operating income | $906M | $844M | $139M | -$1.96B | -$919M | -$825M |
| Net income | $704M | $549M | -$10.1M | -$2.05B | -$1.13B | -$1.05B |
| EPS (diluted) | $16.43 | $9.56 | -$0.15 | -$30.54 | -$16.69 | — |
| Free cash flow | $513M | $744M | $70.9M | -$112M | -$83.0M | -$211M |
| Operating margin | 53.3% | 25.8% | 4.6% | -70.5% | -33.7% | -30.8% |
| Net margin | 41.5% | 16.8% | -0.3% | -73.7% | -41.5% | -39.2% |
| Revenue growth | +2.2% | +92.3% | -8.2% | -7.2% | -1.9% | — |
| Cash + short-term investments | $829M | $345M | $167M | $98.3M | — | — |
| Total debt | $1.0M | $2.86B | $2.56B | $2.83B | $2.88B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 28, 2026)
P/S 0.3x · P/B 0.5x · FCF yield -22.38% · Earnings yield -111.11%

## Analysts
Consensus Hold (mean 3.33 on a 1–5 scale), 3 analysts; mean target USD 14.67 (low 12, high 20).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-08 | Citigroup | Target raised | Neutral | $13 → $18 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-30) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -47.7% | -89.6% |
| S&P 500 (SPY) | +14.8% | +79.1% |
| Per year | -48.0% | -36.4% |
| Volatility (annualized) | 93.0% | 61.7% |
| Max drawdown | -71.8% (Jan 2026→May 2026) | -93.6% (Dec 2021→May 2026) |

## Dividends
QDEL paid no cash dividend in the last five years.

## Short interest
12,991,571 shares sold short, 25.83% of the float, as of Oct 15, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 15, 2026): 14,190,525 shares (-8.4%). Days to cover: 6.3 (short shares ÷ average daily volume).

## Peers (Medical Devices)
INSP (Inspire Medical Systems, Inc.) USD 71.18 +0.30% · ESTA (Establishment Labs Holdings Inc) USD 68.41 -0.81% · BFLY (Butterfly Network, Inc.) USD 7.51 -3.84% · UFPT (UFP Technologies, Inc.) USD 293.3 +2.55% · TMDX (TransMedics Group, Inc.) USD 67.12 +0.33% · ALMR (Alamar Biosciences, Inc.) USD 34.04 -0.76%

## More
Full page: https://nexqual.com/QDEL · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.18 | $0.93 | -80.9% | $627.7M | 1 |
| Next quarter (ends 2026-12-31) | $0.47 | $0.97 | -51.9% | $665.3M | 1 |
| Current fiscal year (ends 2026-12-31) | $0.77 | $1.85 | -58.1% | $2.54B | 2 |
| Next fiscal year (ends 2027-12-31) | $1.43 | $2.46 | -41.9% | $2.59B | 2 |

## Earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Jun 30, 2026 | $0.13 | −$0.05 | Beat +$0.18 | — |
| — | Quarter ended Mar 31, 2026 | −$0.04 | $0.36 | Miss −$0.40 | — |
| — | Quarter ended Dec 31, 2025 | $0.46 | $0.42 | Beat +9.5% | — |
| — | Quarter ended Sep 30, 2025 | $0.80 | $0.47 | Beat +70.2% | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).